Search Within

Ingo K Mellinghoff

  1. "2024"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (6)
  3. Review (2)
  4. Correspondence (1)
Groups
  1. GSK Faculty (28)
  2. Human Oncology and Pathogenesis Program (28)
  3. Tow Center for Developmental Oncology (TCDO) (28)
  4. Department of Pathology and Laboratory Medicine (13)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (9)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Anne Reiner (9)
  2. Subhiksha Nandakumar (9)
  3. Robert Young (8)
  4. Tejus Bale (8)
  5. Bridget Holle (7)
  6. Michael Berger (7)

More People

Years
  1. 2024 (28)
Publications
  1. Neuro-Oncology (17)
  2. Clinical Cancer Research (5)
  3. Journal of Clinical Oncology (2)
  4. Acta Neuropathologica Communications (1)
  5. American Society of Clinical Oncology Educational Book (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Oxford University Press (18)
  2. American Association for Cancer Research (5)
  3. American Society of Clinical Oncology (4)
  4. BioMed Central Ltd. (1)

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Update on GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Weller, M.; Berry, D. A.; Blondin, N.; Buxton, M.; Colman, H.; de Groot, J. F.; de la Fuente, M.; Ducray, F.; Ellingson, B.; Gordon, G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • State of the art in low-grade glioma management: Insights from isocitrate dehydrogenase and beyond
    Review

    Schaff, L. R.; Ioannou, M.; Geurts, M.; van den Bent, M. J.; Mellinghoff, I. K.; Schreck, K. C.
    American Society of Clinical Oncology Educational Book (2024)

    Fulltext@MSK | Save
  • A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with adult-type diffuse glioma with an IDH1/2 mutation (INDIGO): Updated efficacy results
    Meeting Abstract

    Mellinghoff, I. K.; van den Bent, M. J.; Touat, M.; Blumenthal, D. T.; Peters, K. B.; Ellingson, B. M.; Clarke, J. L.; Mendez, J.; Yust-Katz, S.; Mason, W. P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of paxalisib in GBM AGILE phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Mellinghoff, I. K.; Cloughesy, T.; Alexander, B.; Berry, D. A.; Buxton, M.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B. M.; Gordon, G. B.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1, safety lead-in and randomized, open-label, perioperative study of vorasidenib combined with pembrolizumab in recurrent or progressive enhancing IDH1 mutant glioma: Trial in progress
    Meeting Abstract

    Wen, P. T.; de la Fuente, M.; Kumthekar, P.; Peters, K.; Clarke, J.; de Groot, J.; Arrillaga-Romany, I.; Puduvalli, V.; Mellinghoff, I.; Chong, R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Lassman, A.; Alexander, B.; Berry, D.; Berry, N.; Buxton, M.; Colman, H.; Gan, H.; de Groot, J.; de la Fuente, M.; Drappatz, J.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • IDH-mutant glioma patients treated with vorasidenib: Ongoing data from the vorasidenib expanded access program
    Meeting Abstract

    Cloughesy, T.; Peters, K.; Colman, H.; Taylor, J.; Mellinghoff, I.; Shih, H.; Chacar, C.; Dewey, J.; Wen, P.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1, randomized, perioperative trial of vorasidenib and ivosidenib in IDH1-mutant diffuse glioma: Updated results
    Meeting Abstract

    Mellinghoff, I.; Wen, P.; Taylor, J.; Taylor, E.; Arrillaga-Romany, I.; Ellingson, B.; Mahboub-Johnson, P.; Baron, E.; Hassan, I.; Steelman, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Miller, A. M.; Nandakumar, S.; Holle, B. M.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Brannon, A. R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save